RemeGenix, Inc RGX is a biopharmaceutical company focused on the development and commercialization of disease altering therapies to prevent cellular degeneration of the brain. As such, the initial product in development by the Company is directed toward addressing Alzheimer s disease, a multi factorial disease with no approved disease altering drugs. More specifically, RGX is developing technologies with well validated, novel models for the treatment of Alzheimer s disease AD , dementia and cognitive decline. Unlike competitive products in development or already approved, RGX lead technologies are focused on addressing the causes of the disease rather than the symptoms.
Quote | Remegenix Inc (OTCMKTS:RGXX)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $4.00 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 02/12/2020 04:31:39 pm |
News | Remegenix Inc (OTCMKTS:RGXX)
Message Board Posts | Remegenix Inc (OTCMKTS:RGXX)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...